From Dolly to CRISPR: How Stem Cell Laws Have Struggled to Keep Up
The rapid advancements in stem cell research, from Dolly the sheep to CRISPR gene editing, are outpacing outdated FDA regulations, leaving many therapies stuck in regulatory limbo.
Day: June 30, 2025